NOTCH3致病变异与年龄相关性黄斑变性风险:台湾生物库与小血管病登记研究
本研究利用台湾生物库数据,将NOTCH3 R544C变异携带者与非携带者按1:10匹配,发现携带者自报AMD的OR为2.26(95%CI 1.38-3.71),但在TAG-SVD队列中携带者AMD患病率23.4% vs 对照13.1%(P=0.10)未达统计学显著。
要点
- NOTCH3 R544C携带者AMD风险升高(OR=2.26,95%CI 1.38-3.71)。
- 年龄(OR=1.06)和糖尿病(OR=5.51)是AMD独立相关因素。
- 医院队列中携带者AMD患病率23.4% vs 13.1%,差异无统计学意义(P=0.10)。
核心结论
- NOTCH3 R544C变异可能与AMD风险增加相关,需进一步研究明确机制。
研究设计与样本
- 台湾生物库中NOTCH3 R544C携带者(n=1134)与非携带者(n=11340)按人口学和心血管因素1:10匹配。
- 在TAG-SVD队列中验证,包括64例NOTCH3 R544C携带者和84例年龄匹配对照,均接受眼科评估。
主要发现
- 台湾生物库中携带者卒中OR=2.23(95%CI 1.30-3.84)、卒中家族史OR=2.05(95%CI 1.78-2.35)、AMD OR=2.26(95%CI 1.38-3.71),其他眼病无差异。
- AMD个体年龄更大,更可能有糖尿病、更高空腹血糖、HbA1c、总胆固醇和低密度脂蛋白水平。
- 多因素分析显示年龄(OR=1.06;95%CI 1.01-1.11)和糖尿病(OR=5.51;95%CI 1.84-14.79)为独立相关因素。
- TAG-SVD队列中携带者AMD患病率23.4%,对照13.1%,差异无统计学意义(P=0.10)。
关键数值与推荐
- 台湾生物库中NOTCH3 R544C携带者AMD的OR=2.26(95%CI 1.38-3.71)。
- 多因素分析中年龄OR=1.06(95%CI 1.01-1.11),糖尿病OR=5.51(95%CI 1.84-14.79)。
- TAG-SVD队列AMD患病率携带者23.4% vs 对照13.1%(P=0.10)。
临床怎么用
- NOTCH3 R544C携带者应关注AMD风险,尤其合并糖尿病时。
- 对携带者进行眼科评估可能有助于早期发现AMD。
局限性
- 台湾生物库中AMD为自报结果,可能存在错分偏倚。
- TAG-SVD队列样本量小,AMD患病率差异未达统计学显著。
- 研究为观察性设计,无法确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Age-related macular degeneration (AMD) is a leading cause of central vision loss involving retinal microvascular dysfunction. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), a hereditary small vessel disease caused by NOTCH3 mutations, primarily affects the cerebral vasculature but may also involve the retinal microvasculature. This study investigated the association between the NOTCH3 R544C variant and AMD using the Taiwan Biobank and validated the findings in a hospital-based cohort. METHODS: In the Taiwan Biobank, individuals carrying the NOTCH3 R544C variant were matched with noncarriers (1:10) by demographic and cardiovascular factors. Odds ratios (ORs) for self-reported AMD and other eye diseases were calculated. Validation was performed in the Taiwan-Associated Genetic and Non-Genetic Small Vessel Disease (TAG-SVD) cohort, including 64 NOTCH3 R544C carriers and 84 age-matched controls who underwent ophthalmic evaluation. RESULTS: In the Taiwan Biobank, NOTCH3 R544C carriers (n = 1134) had higher prevalence rates of stroke (OR = 2.23; 95% confidence interval [CI], 1.30-3.84), family history of stroke (OR = 2.05; 95% CI, 1.78-2.35), and AMD (OR = 2.26; 95% CI, 1.38-3.71) compared with matched controls (n = 11,340), but not of other eye diseases. Individuals with AMD were older and more likely to have diabetes, higher fasting glucose, HbA1c, total cholesterol, and low-density lipoprotein levels. Multivariate analysis identified age (OR = 1.06; 95% CI, 1.01-1.11) and diabetes (OR = 5.51; 95% CI, 1.84-14.79) as independent correlates. In the TAG-SVD cohort, AMD prevalence was higher in carriers (23.4%) than in controls (13.1%), although not statistically significant (P = 0.10). CONCLUSIONS: The NOTCH3 R544C variant may be associated with an increased risk of AMD, warranting further studies to clarify the underlying mechanisms.
引用
- Chen CH, Lin CW, Wu SH, et al. NOTCH3 Pathogenic Variant and Risk of Age-Related Macular Degeneration: Findings From the Taiwan Biobank and Small Vessel Disease Registry. Invest Ophthalmol Vis Sci. 2026. PMID: 41841652. doi:10.1167/iovs.67.3.37
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。